Portal de Periódicos da CAPES

Consensus Report of the Fifth International Forum for Liver MRI

2013; American Roentgen Ray Society; Volume: 201; Issue: 1 Linguagem: Inglês

10.2214/ajr.12.9491

1546-3141

Christoph J. Zech, Carlo Bartolozzi, Paulette Bioulac‐Sage, Pierce K. H. Chow, Alejandro Forner, Luigi Grazioli, Alexander Huppertz, H. Laumonier, Jeong Min Lee, Takamichi Murakami, Jens Ricke, Claude B. Sirlin,

Liver Disease and Transplantation

This article reviews topics discussed during the Fifth International Forum for Liver MRI (with a focus on gadoxetic acid-enhanced MRI), which was held in Munich, Germany, in September 2011.Growing evidence shows that gadoxetic acid-enhanced MRI has high sensitivity and specificity for diagnosing liver tumors. Hepatobiliary phase imaging adds new information for the characterization of borderline lesions. However, there is a need to develop standardized criteria for interpretation of gadoxetic acid-enhanced MRI in patients with cirrhosis or other risk factors for hepatocellular carcinoma.